• Definitive agreements with institutional, accredited investors call for issuance and sale of more than 3.5 million shares of common stock
• POAI currently focused on applying AI to develop personalized medical treatments, novel lab media and improved vaccines
• One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has entered into definitive agreements with several investors for the sale of common stock (https://ibn.fm/YcBGM). The agreements with several institutional and accredited investors call for the issuance and sale of 3,650,840 shares of common stock; the stock will be sold at a purchase price of $0.842 per share, resulting in gross proceeds of approximately $3 million for POAI.

The announcement noted that the sale was a registered direct offering priced at-the-market under Nasdaq rules. As part of the agreements, POAI will also issue unregistered warrants to the investors for the purchase of up to 1,825,420 shares of common stock. The offering is expected to close on or about Jan. 12, 2021 and is subject to customary closing conditions. Predictive Oncology plans to use the proceeds from the offering for working capital purposes.

POAI is currently focused on applying AI to develop improved vaccines, personalized medical treatments, and lab media that replicates the body. The company intends to do this by leveraging the invaluable expertise, information and technology available from its subsidiaries Helomics, TumorGenesis and Soluble.

One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome. The company accomplishes this by using Helomics proprietary TumorSpace knowledge base of 150,000 tumor drug response profiles gathered from more than 15 years of clinical testing. Helomics’ database, the largest of its kind in the world, includes information gathered from ovarian, colon, pancreas, and head and neck tumors. The company’s CLIA-certified lab conducts testing and provides information designed to support oncologists in pinpointing personalized patient-treatment options.

POAI’s wholly owned TumorGenesis subsidiary specializes in the field of ovarian cancer, developing tools (kits, reagents and specialty cell-culture media) to grow tumors and cancer cells in a manner that mimics the patient’s own body.  TumorGenesis’ proprietary Oncology Capture Technology Platform isolates and cultures the patient’s heterogenous tumor sample, providing a much better model of the tumor outside the body (ex vivo). These improved ex-vivo tumor models can then be used by researchers to investigate cancer and by clinicians to develop patient-specific treatment plans.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Silicon Valley-based Knightscope produces autonomous security robots (“ASRs”) that provide indoor and outdoor security 24 hours a day, 365 days a year
• Knightscope’s ASRs surveil client properties using an array of artificial intelligence, machine learning and Internet of Things tools
• The ASRs are part of a growing trend in consumer acceptance of technologies that independently monitor circumstances and make recommendations or take actions
• Knightscope’s investor base grew rapidly between early January and early February from 18,000 to 19,000 through the company’s Reg A+ offering

Businesses and homeowners are increasingly adopting Internet of Things (“IoT”) technology to automate and remotely control a wide variety of home and office functions and to monitor for problems, including security risks. Alexa, Ring and Nest have practically become family members within modern households, demonstrating the prevalence of IoT for consumers and driving expectations that smart devices connected online will increase from 35 billion in 2021 to 75 billion by 2025, according to Forbes (https://ibn.fm/nQSNP). Far from simply describing products that monitor behavior and produce data, the IoT has become real-world applications built on their ability to process data quickly and make recommendations or take actions based on its analyses using artificial intelligence (“AI”) and machine learning (“ML”) technologies. Security robot manufacturer Knightscope harnessed IoT developments to enhance the performance of its autonomous sentinels, which monitor, record and relay information according to business client needs. The unsleeping “knights” can function in zero light environments, using infrared and thermal technologies to detect the presence of human activity in the darkness as well as potential fire dangers and then alert human partners in their realm’s round table to developing circumstances (https://ibn.fm/zbshy). The robots may also monitor transmission frequencies, and can respond to community alerts by analyzing license plates to help with searches, for example. Their high-definition streaming video capacity utilizes cameras that surveil a 360-degree panorama. Like the majority of industrial robots being used by corporations to pick and pack orders, weld metal parts and perform inspections, Knightscope has developed the first generation K1 Stationary model as well as the first generation K3 indoor-roving model.  The fourth generation K5 machine improved on its predecessors’ performance in outdoor environments when it was unveiled in late 2018, working in tandem with the sixth generation Knightscope Security Operations Center (“KSOC”) management platform (https://ibn.fm/4CCIh) and showcasing the company’s ability to continually respond to circumstances with progressive features as it was deployed the following months. CEO William Santana Li describes the company’s autonomous security robots (“ASR”) as the means of making the United States the safest country in the world. “Each one proudly displays the stars and stripes, signifying our patriotic duty to our country,” Santana Li says in an investor relations video (https://ibn.fm/HfY85). “Just take a moment to imagine the positive impact we can have together on our schools, justice system, government, communities and, most importantly, the safety of your loved ones. It would be an absolutely priceless achievement,” he says. “The country and Knightscope are both at an inflection point. Self-driving technology, artificial technology and robotics are going to change the world dramatically, and we’re right in the middle of it all here in the heart of Silicon Valley.” Knightscope robots are operating across the country’s five continental time zones 365 days a year, 24 hours a day. The company’s social media blog recently announced that its investor pool has rapidly grown from 18,000 to 19,000 in a month’s time (https://ibn.fm/diTxP) through its Reg A+ offering, with security officers of large corporations, shopping mall directors, municipal police officers and federal agents on board. For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• Growth that began in 2020 will only continue with additional deals, plans in place
• Co-founder, COO Robin Lawson leads from front line with hands-on approach
• Global esports revenue expected to expand at compound annual growth rate of 24.4% from 2020 to 2027

Robin Lawson, co-founder and COO of the online gaming operator Mobius Interactive, recently shared with G&M News that the company is confident the impressive growth that began in 2020 with the launch of three new brands will only continue (https://ibn.fm/M035S). During the interview, Lawson shared his leadership style and announced future plans for the company. Mobius launched in September of 2020 with three diverse brands: Mobius Bet, Aragon Casino and Club Double. In addition to the brands, the company runs a Mobius Affiliates platform, offers a full loyalty program and has a gamification program that will be launching soon. The company was strategic in launching during the lockdown as Esports viewership and online gaming rapidly increased. When it comes to leadership, Lawson is proactive and engaging, leading from the front line. He believes strongly that it is important to understand each department’s individual daily tasks and prefers to learn with hands-on experience. “Certainly, in a start-up situation, you can encounter many challenges,” said Lawson, “so it’s important that you can work closely with your respective teams to help them solve these issues quickly, allowing them to make decisions which will impact the business positively and learn and grow at the same time. . . . Happy staff, successful business.” As the company continues to grow, it is eyeing numerous opportunities, including the following:

• Movement forward on deals with E-sports tournament companies that desire to showcase their tournaments on the company websites
• Plans in place to provide services in as many Latin American countries as possible
• Enter and go public on exchanges in Canada, the UK and Europe
• Raise funds to enter the competitive and challenging US market

The online gaming industry has performed solidly with global esports reveneues seeing a 15.7% growth from 2019 to 2020 (https://ibn.fm/zlAiq). Viewership growth is due in large part to the worldwide pandemic, which caused the cancellation of typical sporting activities. E-sport tournaments typically ran long and did not hold the attention span of sports betting players who preferred the shorter gameplay of sports. This changed while everyone was staying at home looking for new entertainment opportunities to fill their days. Even as sporting events reopen, the interest in esport tournaments and betting is not waining. Growth is expected to continue with revenues projected to expand at a compound annual growth rate of 24.4% from 2020 to 2027 (https://ibn.fm/CUgXD). Mobius jumped on the opportunity as the viewership and interest in Esports took off. Within three months, they were able to do what no one else in the gaming industry had done before — create and launch three unique and successful brands. For more information, visit the company’s website at www.MobiusInteractive.Ltd. NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Chris Ford joins GOH’s advisory board as company beefs up leadership team to prep for 2021 exploration campaign
• Company is starting phase I drill program at high-priority Rio Loa gold/silver project; continues trenching programs at Coya, Alicia and Roma projects
• GOH is committed to mobilize a world-class exploration talent, one of key success factors in junior mining

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canadian junior exploration company active in the Maricunga Gold Belt of Northern Chile, has announced the appointment of Chris Ford to the company’s advisory board; Ford will be a significant contributor to the company’s Chilean operations.

According to the announcement, Ford has extensive experience with gold mining projects in Chile as he previously led the Gold Fields team that discovered the Salares Norte epithermal silver and gold deposits located north of GoldHaven’s Rio Loa project. He will join a team of seasoned mining professionals: Pat Burns, who serves as head of the exploration credited with the discovery of one of the top two copper mines in the world, and Jack Pritting, who led the exploration of Kinross’s La Coipa gold mine.

The latest move is in line with GOH’s strategic ambition to attract a robust talent pool as the company believes that essential to its success is the right people along with the right product and right timing enhanced by strong commitment. The latest addition to its supervisory board shows that GOH is poised for growth as the company commences it’s 5000m phase I drill program at the Rio Loa Project.

In addition to the commencement of drilling, GOH is mobilizing equipment to start a trenching program at the Coya, Alicia and Roma projects to include rock sampling and geophysics. Previous trenching conducted at Rio Loa in December 2020 exposed additional hydrothermal breccias, important as they form the host rocks to the gold and silver mineralization in deposits such as the Gold Field’s Salares Norte project located 25km to the north of the Rio Loa asset (https://ibn.fm/0Bmgu).

With prices, production and consumption of minerals and metals expected to improve in 2021, Fitch Solutions assigns a positive outlook for next year. It forecasts that global gold production will increase from 106 million oz. in 2020 to 133 million oz. by 2029, growing at an average annual rate of 2.5% — a considerable acceleration compared to 2016–2019, when the growth was just at 1.2% annually

Management is confident that GoldHaven operates in one of the most prospective gold districts globally, where the company runs seven projects with unique land position, a combination that is starting to yield attractive targets. The new addition to GOH’s management team confirms the company’s strategic commitment to secure world-class exploration talent, one of the junior mining industry’s key success factors, as it prepares to start exploration campaigns.

For more information, visit the company’s website at www.GoldHavenResources.com.

NOTE TO INVESTORS: The latest news and updates relating to GHVNF are available in the company’s newsroom at http://ibn.fm/GHVNF

• PACR private placement comprised of 8,333,333 units for possible gross proceeds of $1.5 million
• Funding to support Company’s continued progress in current, potential efforts
• An example of Pac Roots projects includes JV with Rock Creek Farms, which resulted in profitable first harvest that delivered 200% ROI

Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) has announced a non-brokered private placement (https://ibn.fm/tYble) to strengthen its financial position as it focuses on the future of genetics and its commitment to quality over quantity. Headquartered in Canada, Pac Roots is dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach. The announcement of the private placement noted that up to 8,333,333 units would be offered at CDN$0.18 per unit for a potential of $1.5 million gross proceeds for the Company. Each unit consists of one common share in the capital of the PACR along with one common share purchase warrant, which will entitle the warrant holder the right to acquire an additional common share at CDN$0.30 for 36 months after the offering closing. The offering is expected to close on or about Feb. 12, 2021, subject to typical approvals. Pac Roots announced several significant initiatives in the past year, and the additional funding will support the Company’s continued progress and success in these projects as well as other operational expenses. Included in Pac Roots portfolio is a joint venture with Rock Creek Farms, which resulted in a profitable first project last fall that garnered an ROI of 200% (https://ibn.fm/AIN8Z). The completion of its successful 2020 outdoor premium CBD hemp harvest marks PacRoots’ first production project, and the impressive results are proof of how vital the combination of farming experience, suitable genetics, and an ideal climate and region are in producing a successful CBD hemp crop. The Company, which through a joint venture holds a Health Canada license to cultivate, sell, import, export, possess and process industrial hemp, announced that the yield for the 100-acre pilot outdoor hemp CBD harvest at Rock Creek Farms was “much higher than our expectations.” The total biomass harvest yielded more than 105,000 pounds. In the announcement of the harvest, Pac Roots noted that “with a very low cost to harvest, as opposed to greenhouse costs that currently dominate the industry, the Company has an opportunity to disrupt categories within the hemp industry. PacRoots believes that the largest advantage it has over its competition is its low-cost production, giving the Company the ability to be extremely price competitive on the market while continuing to maintain healthy profit margins.” “We are very proud of our team and partners at Rock Creek Farms who have been committed to the vision and dedicated to achieving success,” noted Pac Roots president and CEO Patrick Elliott. “In light of some unusual extreme weather, the team was able to react quickly and minimize crop loss from the early freezing temperatures experienced during the harvest. The JV is fortunate to have recovered as much tonnage as was realized under the circumstances that culminated at other farms in the Province. PacRoots and our partners are thrilled to build on this success as we launch into 2021 with various exciting projects.” For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• InsuraGuest expanded platform integration to 82 different property management systems and now connects with 90% of all property management systems used by the biggest names in hospitality
• InsuraGuest Hospitality Liability coverage can lower a facility’s claim ratio and risk profile, which may decrease the property’s general liability premiums, save money, time and aggravation for hotel and vacation rental operators
• InsuraGuest is pioneering a new standard, disrupting the insurance industry with its proprietary insurtech platform

InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF), a leader in the insurtech sector (insurance + technology), recently marked another major milestone in its mission to revolutionize the insurance industry. InsuraGuest is disrupting status quo insurance markets by leveraging its proprietary software platform to deliver digital insurance products that provide better benefits at lower costs across multiple industry sectors. One of the initial primary targets is the hospitality industry and recent news from InsuraGuest marks a new milestone in the company’s reach and scope of business in the hospitality sector. InsuraGuest recently announced it has expanded the reach of its insurtech platform to fully integrate with 82 different property management systems which are used by some of the biggest names in the hospitality industry. Utilizing InsuraGuest’s proprietary API enables hospitality properties to transfer some of their liability exposure from their facilities to InsuraGuest Hospitality Liability policies. Liability coverage for medical expenses, accidental property damage, stolen goods, or other mishaps usually has limitations and high deductibles. When these incidents are covered by a property’s general liability insurance it could cost a facility more than the actual event. InsuraGuest provides a layer of protection that responds to the property directly when guests experience mishaps. If accidents do happen, it’s quick and easy to file a claim. A large portion of a hotel, motel or Airbnb operator’s claims result from small property or medical claims. These are most often charged against the facility’s general liability policy and the frequency of these small claims drives up premium prices. By using InsuraGuest, the risk is transferred from the hotel or vacation rental operator by having guests pay a small fee per night. InsuraGuest collects the fees and then pays out these claims, bypassing claims against the general liability policy. This can lower a facility’s claim ratio and risk profile, which may decrease the property’s general liability premiums, saving money, time and aggravation for hotel and vacation rental operators. This is especially important to America’s small businesses looking for any edge to improve profitability. “Increasing our platform integration to 82 different property management systems gives us the ability to connect with over 90% of the systems in use today, systems which are used by Hilton, Marriott, Hyatt, Wyndham and Airbnb,” stated Douglas Anderson, chairman and CEO of InsuraGuest Technologies, Inc. InsuraGuest Technologies is focused on adding value to the insurance market and its customers by integrating insurance innovation and technology into a single flexible package. The company is guided by its motto, “Digital insurance reimagined, reinvented, revolutionized.” InsuraGuest is pioneering a new standard, disrupting the insurance industry with its proprietary insurtech platform, providing cost savings and an array of digital business insurance solutions with flexible pricing delivered in less than 60 seconds. The future of insurance has arrived. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• Chinese mobile-based social and entertainment platform operator Momo is regrouping and revisiting its successes after suffering a pair of adverse conditions resulting from government concerns and pandemic problems
• Momo has developed a prominent reputation as “China’s Tinder” through its Tantan dating service platform and its Momo streaming video app
• The company saw some of its top leadership positions change last year in response to declines in revenue and stock value
• The company has generated some encouraging reports since the start of the year with a brief surge in stock value and forecasts that anticipate it will “retain growth momentum on both VAS and live broadcasting”

Chinese social media wonder Momo (NASDAQ: MOMO) is responding to a test of its mettle in the wake of adverse economic factors brought on by a brief battle with the country’s content regulators followed by the rise of the global COVID-19 pandemic. Momo owns the Tantan dating service known as “China’s Tinder” as well as its own-brand Momo live video streaming platform, two of the top dating and social interaction apps in China. Popular features include virtual gift-giving and blind date matching with other active users whose photo profile is blurred until after at least 20 messages have been exchanged. But the company saw significant declines in revenue and stock value during 2020 after the pandemic’s virus gained worldwide attention when it reportedly originated in a Chinese province and businesses there ground to standstill amid national efforts to stop the virus’ spread. Far from down for the count, Momo’s monthly active users (“MAUs”) numbered 113.6 million and net revenues stood at US$554.8 million as of last year’s third quarter financial report, the most recent for the company (https://ibn.fm/ePte4). The company monetized Tantan’s dating features, driving an increase in value added services (“VAS”) revenues by 27 percent YOY, according to the Q3 report. The company’s CEO stepped down in November to become the executive chairman of the board of directors and the chief strategy officer stepped down in December for personal reasons but will continue to serve as a senior advisor to the Company, according to the report. In January, Momo’s shares enjoyed a brief surge after well-known options trader Jon Najarian talked about “unusual activity” in call options and mentioned his Momo options in furtherance of the discussion on CNBC’s Fast Money program (https://ibn.fm/lRutu), and the company continues working to achieve a sustainable rebound. “The third quarter of 2020 was a busy quarter for us. As a result of management’s commitment and the persistence of our colleagues, the structural reform within the core live broadcasting business has achieved initial success,” new CEO Li Wang stated in the Q3 report. “Although we have more hard work to do down the path, what we have achieved so far gives us the confidence that our live streaming business has entered into a virtuous cycle supported by a sustainable content ecosystem.” Despite the challenges, Deutsche Bank analyst Leo Chiang told Yahoo! Finance that Tantan’s average revenue per user (“ARPU”) has been “growing sharply sequentially” and that he expects Tantan to “retain growth momentum on both VAS and live broadcasting but in a moderate manner.” Chiang foresees a gradual turnaround in the second half of the year (https://ibn.fm/lsVU0). For more information on Momo Inc., visit the company’s Investor Relations web page at https://momoinc.gcs-web.com.

• FDA has authorized 225-plus diagnostic tests for COVID-19 since pandemic began
• CareStart(TM) COVID-19 antigen test received FDA authorization in July 2020
• UME carries CareStart antigen kit, a powerful component of COVID-19 screening process

Since the beginning of the COVID-19 pandemic, the U.S. Food and Drug Administration (“FDA”) has authorized more than 225 diagnostic tests for COVID-19 in an effort to provide growing resources to combat the disease. United Medical Equipment Business Solutions Network (“UME”), a company committed to offering a comprehensive line set of COVID-19 products, recently added one of those tests — the CareStart(TM) COVID-19 rapid antigen kit — to its product line.

“The FDA strongly supports innovation in test development and we have worked tirelessly with test developers to support the shared goal of getting more accurate and reliable tests to Americans who need them,” said Jeff Shuren, MD., J.D. and director of the FDA’s Center for Devices and Radiological Health (https://ibn.fm/rVMjI).

The CareStart COVID-19 antigen test received FDA authorization in July 2020 (https://ibn.fm/iFrI8). In a letter to Access Bio Inc., the company that manufactures the test, FDA chief scientist Denise M. Hinton explained that the secretary of the Department of Health and Human Services (“HHS”) had “determined a public health emergency existed that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19.”

Hinton noted that the circumstances justify the authorization of diagnostic measures designed to detect or diagnose the virus that causes COVID-19, and therefore, “I am authorizing the emergency use of your product,” Hinton wrote.

The CareStart COVID-19 Antigen packaging material notes that “due to the highly contagious nature and global spread, SARS-CoV-2 . . . continues to have devastating impacts on healthcare systems and the world economy, including the U.S.” (https://ibn.fm/OSKkr). Systematic screening and detection of both clinical and asymptomatic systems is an essential piece of ending the SARS-CoV02 pandemic, and the CareStart antigen kit can be a key component of that screening process. The innovative test features a 10-minute processing time, identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike.

The CareStart product is part of UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance of medical experts and includes ongoing, data-driven COVID-19 testing. In addition to the CareStart COVID-19 Antigen tests, UME provides a wide array of other COVID-19 supplies and products, including sanitizers, gloves and face shields, thermometers, hoods and masks.

UMEs’ mission is to provide guidance for caregivers, veterans, the aging population and the medical community through its robust medication management and telehealth applications. In addition, the company recognizes the importance of being socially responsible as a corporation by giving back to the world through emergency assistance grants awarded to seniors, with an emphasis on veterans, by supporting nonprofits in their missions, and by supporting the American economy by providing work-at-home opportunities.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

• Recent article finds that data remains one of main drivers of medical research in 2021.
• New technologies employing AI powered by big data provide new solutions for tackling health problems, expand possibilities of clinical research
• RYAH combines power of devices combined with data to impact future of medical research to advance treatment of various medical conditions

A recent Becker’s Hospital Review article cites 10 emerging trends in health IT that will shape this field in 2021, reporting that big data management is becoming a need as the use of artificial intelligence (“AI”) and machine learning in healthcare continues to blossom (https://ibn.fm/bMPIY). With the increasing demand in the medical space for application of analytics powered by novel technology, RYAH Group is set to benefit as a leading digital health care analytics and technology company committed to advancing the world’s transition to remote-health solutions and data analytics in patient treatments. With the digitalization of medical records and improved medical analytics coupled with a proliferation of wearables, there has been an explosion of medical data over the past decade. That explosion has led to a revolution in medical and health-care research. The vast amount of data available for analysis enables AI-powered algorithms to transform the medical field more than ever before, helping to define what is healthy and to diagnose, treat and prevent any deviations from the ideal standard. The applications go beyond the individual level, offering solutions to tackle health challenges at the level of humanity. Blossoming of artificial intelligence and machine learning in health care, driven by a combination of wearables and other biomedical devices, will continue to transform clinical research and treatment protocols as well as increase the virtual-care capabilities of health providers, the article observes. “AI is not new in healthcare,” the article notes. “But in the last year AI became crucial in developing predictive models for COVID-19 cases spreading across the country. . . . The field will continue to evolve and become more integrated with clinical care in the coming years.” Technological advancements make these developments possible as the data continue to be the major trend shaping medical research. The article reports that big data management becomes mission critical as the pandemic highlighted the need for centralized and efficient data management. The data-gathering and reporting efforts accelerated during the virus outbreak, propelling organizations of all sizes to consider cloud implementations to securely store and coordinate data as secure medical research becomes a priority. As a company committed to leveraging the value of health devices combined with data to positively impact the future treatment of patients with various medical conditions, RYAH is set to be at the forefront of the data-driven medical future. Indispensable in modern medical research, data is at the core of the company’s strategic approach. RYAH aggregates data collected by its product ecosystem, creating a HIPAA-compliant database enhanced by AI-powered solutions designed to analyze and clarify complex relationships between peer-reviewed research, consumer feedback and therapeutic plants. As the company specializing in unlocking data in the complete therapeutic plant lifecycle – from seed to consumption – RYAH appears strategically placed in the $100.3 billion medical plant market, with the potential to capitalize on growth opportunities enabled by both the IoT and data intelligence (https://ibn.fm/wKPTg). For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH

• Investor uncertainty rising as volatility continues to negatively affect stock market
• SRAX’s Sequire investor analytics platform provides actionable insights into investor behaviors for public companies
• Sequire has grown to 3 million+ active users across 90 public companies since 2019
• Q3 2020 performance includes $6.7 million in bookings, 37% increase in subscriptions, 161% year-over-year and 124% quarter-over-quarter revenue growth

Despite record levels of unemployment, threats of extreme inflation and runaway government spending, the stock market appears to have decoupled from the greater economy with record highs amid unprecedented levels of volatility (https://ibn.fm/fEiHi). As uncertainty among investors continues to grow, many public companies are choosing clarity over confusion through the use of Sequire, SRAX Inc.’s (NASDAQ: SRAX) SaaS platform that helps its users unlock the power of investor data so they can activate marketing campaigns that engage both current and prospective investors.

There’s never been a greater need for actionable, reliable investor data than in recent weeks. Market volatility has reached unparalleled levels, credited mostly to irrational trading, investor reactions to new government policies, derivatives speculation and anticipated earnings reports. “There’s a lot of news to digest for investors,” said J.J. Kinahan, chief market strategist at TD Ameritrade. “We’ve had such an incredible run, and 20% of the S&P 500 are releasing earnings this week.”

Sequire is the answer for many public companies looking to harness the power of big data for reliable analytics derived from the platform’s 3 million+ active users, a group which includes investors and traders from over 90 public companies (https://ibn.fm/0D6lL). The platform’s unique set of tools help users obtain insights through investor intelligence and outreach, warrant tracking, survey creation, event promotion and roadshows.

“The platform is an absolute game-changer for public companies and their shareholders,” said LD Micro founder Chris Lahiji in statements about the recent acquisition of the company by SRAX. “Both companies believe that one day executives will rely on Sequire the same way investors rely on Bloomberg.”

Sequire’s sales performance in 2020 was outstanding with over $6.7 million in bookings in Q3, its first positive quarter EBITDA. Along with a 37% increase in subscriptions, the platform experienced impressive 161% year-over-year and 124% quarter-over-quarter revenue growth.

“Sequire is changing the way public issuers interact with and engage their investors, and it shows,” said SRAX CEO and Founder Christopher Miglino (https://ibn.fm/I5gHA). “We are pleased to report our first quarter of positive EBITDA from our Sequire segment.”

Besides Sequire, SRAX is also focused on building the largest and most reliable opted-in data sets across a broad range of industry verticals. The Company is dedicated to providing brands and companies across the CPG, luxury, and lifestyle spaces with high-quality data that provides key, actionable insights integral to strategic marketing campaigns.

SRAX is a financial technology company that helps public companies unlock the power of data through Sequire, its premier investor intelligence and communications platform. Sequire helps companies track investor behaviors and identify trends for use in campaigns to engage current and potential investors across multiple marketing channels.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX